Ignite Creation Date:
2025-12-24 @ 10:23 PM
Ignite Modification Date:
2026-01-27 @ 7:39 PM
Study NCT ID:
NCT02740335
Status:
COMPLETED
Last Update Posted:
2023-03-08
First Post:
2016-04-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.
Sponsor:
Octapharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-08
Start Date Type:
ACTUAL
Primary Completion Date:
2022-02-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-02-23
Completion Date Type:
ACTUAL
First Submit Date:
2016-04-05
First Submit QC Date:
None
Study First Post Date:
2016-04-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-10-27
Results First Submit QC Date:
None
Results First Post Date:
2023-03-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-06
Last Update Post Date:
2023-03-08
Last Update Post Date Type:
ACTUAL